NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.

Palmieri, C; Cleator, S; Kilburn, L S; Kim, S B; Ahn, S-H; Beresford, M; Gong, G; Mansi, J; Mallon, E; Reed, S; Mousa, K; Fallowfield, L; Cheang, M; Morden, J; Page, K; Guttery, D S; Rghebi, B; Primrose, L; Shaw, J A; Thompson, A M; Bliss, J M; Coombes, R C

Palmieri, C; Cleator, S; Kilburn, L S; Kim, S B; Ahn, S-H; Beresford, M; Gong, G; Mansi, J; Mallon, E; Reed, S; Mousa, K; Fallowfield, L; Cheang, M; Morden, J; Page, K; Guttery, D S; Rghebi, B; Primrose, L; Shaw, J A; Thompson, A M; Bliss, J M; Coombes, R C.

Affiliation

Palmieri C; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Breast Cancer Res Treat ; 148(3): 581-90, 2014 Dec.

Article de En | MEDLINE | ID: mdl-25395314

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique / Antinéoplasiques hormonaux / Traitement néoadjuvant / Inhibiteurs de l'aromatase Type d'étude: Clinical_trials / Systematic_reviews Aspects: Patient_preference Limites: Adult / Female / Humans / Middle aged Langue: En Journal: Breast Cancer Res Treat Année: 2014 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google